Hyperuricaemia and the metabolic syndrome in type 2 DM.
BACKGROUND
Elevated serum uric acid levels (SUA) have been associated with an increased risk of cardiovascular diseases and the metabolic syndrome (MetS) and are often reported to be higher in females than in males. The aim of this report is to determine the prevalence and clinical correlates of hyperuricaemia and also to evaluate associations with the MetS in people with type 2 diabetes mellitus (DM).


METHODS
This was a cross-sectional study conducted in people with type 2 DM in Lagos, Nigeria. Hyperuricaemia was defined by cut-off values of > 7 mg/dl for men and > 6 mg/dl for women. The diagnosis of MetS was made using the new definition by the American Heart Association and other related bodies. Clinical and biochemical parameters were compared between subjects with hyperuricaemia and normouricaemia. Statistical analysis included usage of Student's t test, Pearson correlation coefficients, multivariate regression analysis and chi square.


RESULTS
601 patients with type 2 DM aged between 34-91 years were recruited for the study. The prevalence rates of hyperuricaemia and the MetS were 25% and 60% respectively. The frequency of occurrence of hyperuricaemia was comparable in both genders (59% vs 41%, p = 0.3). Although, the prevalence of the MetS in subjects with hyperuricaemia and normouricaemia was comparable (61 vs 56%, p = 0.1), a higher proportion of hyperuricaemic subjects had 3 or more components of the Mets compared with normouricaemic subjects. Possible predictors of hyperuricaemia include central obesity, smoking and elevated serum triglycerides (TG). SUA levels were found to be positively and significantly associated with serum TG (r = 0.2, p = 0.0001) and total cholesterol (r = 13, p = 0.001).


CONCLUSIONS
The prevalence of hyperuricaemia in subjects with type 2 DM is comparable in both genders and possible predictors of hyperuricaemia are potentially modifiable. SUA is positively and significantly associated with serum TG and total cholesterol.
Ogbera
Anthonia O
AO
Department of Medicine, Lagos State University Teaching Hospital, Ikeja, Lagos, Nigeria. oogbera@yahoo.co.uk
Azenabor
Alfred O
AO
J Hum Hypertens. 2009 Feb;23(2):113-21
18719615
J Gerontol A Biol Sci Med Sci. 2002 Oct;57(10):M660-4
12242321
Chest. 2007 May;131(5):1473-8
17494796
JAMA. 1993 Jul 21;270(3):354-9
8315780
Clin Chem. 1972 Jun;18(6):499-502
4337382
Clin Chem. 1973 May;19(5):476-82
4703655
Asia Pac J Clin Nutr. 2009;18(1):81-7
19329400
Stroke. 1998 Mar;29(3):635-9
9506605
Intern Emerg Med. 2008 Dec;3(4):313-8
18320146
Am J Physiol Renal Physiol. 2006 Mar;290(3):F625-31
16234313
Metabolism. 2008 Jun;57(6):845-52
18502269
Metabolism. 2007 Jun;56(6):751-6
17512306
Arch Intern Med. 1973 Sep;132(3):401-10
4783021
Ethn Dis. 2007 Autumn;17(4):676-81
18072378
Atherosclerosis. 2008 Apr;197(2):638-45
17945241
Acta Med Scand. 1988;224(6):549-55
3207067
BMC Public Health. 2004 Mar 25;4:9
15043756
Int J Obes Relat Metab Disord. 1996 Nov;20(11):975-80
8923153
J Zhejiang Univ Sci B. 2007 Aug;8(8):593-8
17657863
Int J Epidemiol. 1999 Oct;28(5):888-93
10597987
J Assoc Physicians India. 2006 Oct;54:797-810
17214277
Curr Opin Lipidol. 2007 Jun;18(3):263-70
17495599
Circulation. 2009 Oct 20;120(16):1640-5
19805654
Blood Press. 2009;18(5):268-72
19919398
Diabetes Care. 2008 Feb;31(2):361-2
17977935
N Engl J Med. 1966 Sep 1;275(9):457-64
5917940
Clin Chem. 1977 May;23(5):882-4
192488
J Hum Hypertens. 1994 Sep;8(9):677-81
7807497
Am J Epidemiol. 1988 Feb;127(2):321-36
3337086
J Biol Chem. 1952 Mar;195(1):357-66
14938387
Nihon Rinsho. 1996 Dec;54(12):3369-73
8976122
Am J Clin Nutr. 1967 Jul;20(7):777-82
6036267
Metabolism. 1998 Apr;47(4):435-8
9550542